Dashboard
Manage Tickers

TSX:CEE


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ na
-- x --
-- x --
-- - --
na - na
0
na
na
na
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

endeavour-fires-ceo-for-misconduct-and-irregularities-linked-to-asset-sale
Endeavour Fires CEO For Misconduct And Irr...
01/05/2024 19:15:45

Endeavour appointed Ian Cockerill, the Deputy Chairman, as the new CEO, effective immediately.

Core News & Articles
RBC Capital Maintains Sector Perform on Ce...
03/24/2021 11:08:04

RBC Capital analyst Tyler Broda maintains Centamin (TSX:CEE) with a Sector Perform and lowers the price target from C$128 to...

Core News & Articles
BMO Capital Downgrades Centamin to Market ...
08/10/2020 14:17:42

BMO Capital analyst Raj Ray downgrades Centamin (TSX:CEE) from Outperform to Market Perform.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION